Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Tsongalis

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Critical Reviews in Clinical Laboratory Sciences|May 12, 2001
HER2: the neu prognostic marker for breast cancerG J Tsongalis, A Ried
Annals of Clinical and Laboratory Science|September 1, 1994
In situ amplification: detection of target sequences in whole tissuesG J Tsongalis, L M Silverman
Clinical Chemistry|May 1, 1995
Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformationW B Coleman, G J Tsongalis
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|April 1, 1997
Application of forensic identity testing in a clinical setting. Specimen identificationG J Tsongalis, M M Berman
Anticancer Research|March 4, 2000
The role of genomic instability in human carcinogenesisW B Coleman, G J Tsongalis
Annals of the New York Academy of Sciences|November 5, 1997
Correlation between morphologic and nonmorphologic prognostic markers of neuroblastomaV V Joshi, G J Tsongalis
Archives of Pathology & Laboratory Medicine|November 1, 1993
Molecular pathology of the fragile X syndromeG J Tsongalis, L M Silverman
The American Journal of Cardiology|June 9, 2001
Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseasesA H Wu, G J Tsongalis
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|June 1, 2001
Coexistence of the methylenetetrahydrofolate reductase single-nucleotide polymorphism (C677T) in patients with the factor V Leiden or prothrombin G20210A polymorphismsD R Linfert, G J Tsongalis
American Clinical Laboratory|August 16, 2001
Point mutation detection technology for the new-century laboratoryP Bean, A Ryan, G J Tsongalis
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Critical Reviews in Clinical Laboratory Sciences|May 12, 2001
HER2: the neu prognostic marker for breast cancerG J Tsongalis, A Ried
Annals of Clinical and Laboratory Science|September 1, 1994
In situ amplification: detection of target sequences in whole tissuesG J Tsongalis, L M Silverman
Clinical Chemistry|May 1, 1995
Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformationW B Coleman, G J Tsongalis
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|April 1, 1997
Application of forensic identity testing in a clinical setting. Specimen identificationG J Tsongalis, M M Berman
Anticancer Research|March 4, 2000
The role of genomic instability in human carcinogenesisW B Coleman, G J Tsongalis
Annals of the New York Academy of Sciences|November 5, 1997
Correlation between morphologic and nonmorphologic prognostic markers of neuroblastomaV V Joshi, G J Tsongalis
Archives of Pathology & Laboratory Medicine|November 1, 1993
Molecular pathology of the fragile X syndromeG J Tsongalis, L M Silverman
The American Journal of Cardiology|June 9, 2001
Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseasesA H Wu, G J Tsongalis
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|June 1, 2001
Coexistence of the methylenetetrahydrofolate reductase single-nucleotide polymorphism (C677T) in patients with the factor V Leiden or prothrombin G20210A polymorphismsD R Linfert, G J Tsongalis
American Clinical Laboratory|August 16, 2001
Point mutation detection technology for the new-century laboratoryP Bean, A Ryan, G J Tsongalis
Pageof 6